Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Goss

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
American Journal of Human Genetics|December 1, 1999
The importance of a family history of breast cancer in predicting the presence of a BRCA mutationW D Foulkes, J S Brunet, E Warner, et al.
Cancer Research|August 1, 1993
Mutations of the p53 gene do not occur in testis cancerH Q Peng, D Hogg, D Malkin, et al.
Seminars in Hematology|April 1, 1994
Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary reportP E Goss, R Burkes, L Rudinskas, et al.
Seminars in Oncology|February 1, 1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancerF A Shepherd, W K Evans, P E Goss, et al.
Breast Cancer Research and Treatment|December 8, 2009
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal womenT Cigler, D Tu, M J Yaffe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancerP E Goss, S Fine, K Gelmon, et al.
Bone|March 9, 2004
The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized ratsP E Goss, S Qi, R G Josse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II studyP E Goss, F A Shepherd, J G Scott, et al.
Cancer|April 1, 1994
Extragonadal germ cell tumors. A 14-year Toronto experienceP E Goss, L Schwertfeger, M E Blackstein, et al.
Breast Cancer Research and Treatment|April 7, 2000
Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancerP E Goss, A Oza, R Goel, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
American Journal of Human Genetics|December 1, 1999
The importance of a family history of breast cancer in predicting the presence of a BRCA mutationW D Foulkes, J S Brunet, E Warner, et al.
Cancer Research|August 1, 1993
Mutations of the p53 gene do not occur in testis cancerH Q Peng, D Hogg, D Malkin, et al.
Seminars in Hematology|April 1, 1994
Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary reportP E Goss, R Burkes, L Rudinskas, et al.
Seminars in Oncology|February 1, 1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancerF A Shepherd, W K Evans, P E Goss, et al.
Breast Cancer Research and Treatment|December 8, 2009
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal womenT Cigler, D Tu, M J Yaffe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancerP E Goss, S Fine, K Gelmon, et al.
Bone|March 9, 2004
The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized ratsP E Goss, S Qi, R G Josse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II studyP E Goss, F A Shepherd, J G Scott, et al.
Cancer|April 1, 1994
Extragonadal germ cell tumors. A 14-year Toronto experienceP E Goss, L Schwertfeger, M E Blackstein, et al.
Breast Cancer Research and Treatment|April 7, 2000
Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancerP E Goss, A Oza, R Goel, et al.
Pageof 8